Tn antigen
Tn antigen is a carbohydrate antigen that is considered an important biomarker in the field of oncology, particularly in the diagnosis and monitoring of certain types of cancer. The presence of Tn antigen is associated with tumor progression and metastasis, making it a significant target for cancer research and therapeutic strategies.
Overview[edit | edit source]
Tn antigen is a simple O-linked glycan that consists of a single N-acetylgalactosamine (GalNAc) molecule attached to the hydroxyl group of serine or threonine residues in glycoproteins. This antigen is normally found in the human body in a highly modified form, as part of complex polysaccharides. However, in cancerous cells, due to aberrant glycosylation processes, the unmodified Tn antigen is expressed on the cell surface. This abnormal expression is implicated in the evasion of immune surveillance, tumor growth, and metastasis.
Clinical Significance[edit | edit source]
The detection of Tn antigen in serum or on the surface of cells can serve as a diagnostic and prognostic marker for various types of cancers, including breast cancer, prostate cancer, and colorectal cancer. Its presence is often associated with a poor prognosis due to its role in facilitating tumor cell invasiveness and metastasis.
Tn Antigen in Cancer Therapy[edit | edit source]
Research into targeting the Tn antigen for cancer therapy is ongoing. Strategies include the development of vaccines that elicit an immune response against tumor cells expressing the Tn antigen, and the creation of antibodies that specifically target this antigen. These approaches aim to improve the specificity of cancer treatments, reducing the impact on healthy cells and potentially leading to better outcomes for patients.
Related Glycan Antigens[edit | edit source]
The Tn antigen is closely related to other glycan antigens, such as the T antigen (also known as the Thomsen-Friedenreich antigen) and the sialyl-Tn antigen. These antigens share similar pathways of aberrant glycosylation in cancer cells and are studied for their roles in tumor biology and their potential as biomarkers and therapeutic targets.
 | This oncology article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
